IL1A and systemic sclerosis: Similarly, serum IL‐1α was detectable in 75% (35/47) of HC and 74% (78/105) of SSc patients, and IL‐1β was detectable in 55% (26/47) of HC and 65% of (68/105) of SSc patients.